Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Glecirasib |
Trade Name | |
Synonyms | JAB21822|JAB 21822|JAB-21822 |
Drug Descriptions |
Glecirasib (JAB-21822) is an inhibitor of KRAS G12C, with potential antitumor activity (J Clin Oncol 40, no. 16_suppl (June 01, 2022) 3089-3089). |
DrugClasses | KRAS G12C inhibitor 34 |
CAS Registry Number | NA |
NCIT ID | C181904 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cetuximab + Glecirasib | Cetuximab Glecirasib | 0 | 1 |
Glecirasib | Glecirasib | 0 | 1 |
Glecirasib + JAB-3312 | Glecirasib JAB-3312 | 0 | 0 |